Loading…
← CockpitCompetitor Analysis › BRBR BellRing Brands, Inc.Open in the cockpit ↗

BellRing Brands, Inc.BRBRCompetitor analysis, valuation and peers

United States · USD·Health Care›Beverages: Non-Alcoholic
Momentum leader 97
Mkt cap
$1.59B
US dollars, full cap
Free float
98%
of shares outstanding
$/day
$43.4M
20-day average traded
Fwd P/E
10.6×
forward earnings
ROIC−WACC
+27.0 pp
WACC 6.7%
Hurdle
n/a
no reverse DCF
Official | Implied
B+ / B
agencies · bond market
Next earnings
82 days
8 Feb 2027
Close · USD$13.66
1D+24.1%
1W+36.5%
1M+43.6%
3M+30.7%
6M+52.3%
YTD-48.9%
1Y-46.7%
ATR %5.4%
Beta0.08
52w lowhigh59.3% off high

What BellRing Brands does

No business profile yet.

BellRing Brands at a glance

Size BellRing Brands (BRBR) is a United States Health Care company (Beverages: Non-Alcoholic) with a market value of $1.59B, the 1932nd largest of 3,085 United States companies the cockpit tracks. Shares closed at $13.66 on 18 Nov 2026.

Performance Over six months the shares gained 52.3%, against +3.0% for the median peer and -2.2% for the United States market (cap-weighted) — 3rd highest of 20 in its peer set.

Growth Revenue grew 3.5% over the last twelve months (peer median +15.7%); the operating margin is 10.7% (peer median -1.0%).

Valuation It trades at 10.6× forward earnings against a peer median of 17.6× (5th cheapest of 10).

Capital Return on invested capital runs 27.0 points above its cost of capital (6.7% WACC).

Credit BellRing Brands has 1 bond outstanding ($840M), rated B+ by the agencies and trading like B at a weighted spread of 367 bp.

Short interest Short interest is 12.7% of the free float (30 Oct 2026).

Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012515021 May 202621 Aug 202618 Nov 2026BRBR 151Peer median 110
Six months, rebased to 100: BellRing Brands against the median of its 20 peers (local-currency closes).

BellRing Brands financials

Reported figures in USD; fiscal year ends 2026-09-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue$2.40B$2.40B$2.32B$2.00B$1.67B
Revenue growth—+4%+16%+20%—
Gross profit$599M$621M$772M$672M$504M
EBITDA$276M$298M$463M$424M$316M
Net income$147M$147M$216M$246M$166M
Free cash flown/an/a$256M$198M$214M
Capital expendituren/an/a$4.70M$1.80M$1.80M
Total debt$1.14B$1.05B$1.11B$840M$865M

Quarterly statements and history in the cockpit →

BellRing Brands competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-50%0%+50%SNDAVIRENOVSRPTWGSALVOPSNLANIPBFLYNRIXPGENKLRAAGLKRSAINSPKMTSXRAYMAZEASTHBRBR6-month return →1-month return →
Up and to the right = strong over both horizons. BellRing Brands is the large dot.

Fundamentals: revenue growth against valuation

0%+1,000%+2,000%20×40×ENOVWGSALVOANIPPGENAGLINSPASTHBRBRRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. BellRing Brands is the large dot.

BellRing Brands competitors and peer comparison

How BellRing Brands compares with its peers

Peer set: Sector in the same market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

BellRing Brands against its 20 peers (data as of 18 Nov 2026)
MeasureBRBRPeer medianRank in peer set
1-month return+43.6%-8.6%highest of 21
6-month return+52.3%+3.0%3rd highest of 20
Distance from 52-week high-59.3%-41.5%3rd lowest of 21
Revenue growth (TTM)+3.5%+15.7%9th lowest of 19
Operating margin10.7%-1.0%5th highest of 19
Forward P/E10.6×17.6×5th cheapest of 10
ROIC minus cost of capital+27.0 pp-9.1 pphighest of 18
EV / EBITDA9.5×7.5×4th most expensive of 8
Net debt / EBITDA3.7×3.3×5th most indebted of 11
Bond spread367 bpn/a—

Peer table

Peer set: Sector in the same market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
BellRing Brands BRBRUnited States$1.59B+52%+4%11%10.6×n/an/a
Sonida Senior Living SNDAUnited States$1.59B-11%+70%-8%n/an/an/a
Vir Biotechnology VIRUnited States$1.57B+3%+1,696%-70%n/an/an/a
Enovis ENOVUnited States$1.56B+2%+3%4%7.6×20.0%-6.0%
Sarepta Therapeutics SRPTUnited States$1.56B-15%-19%0%n/a-6.8%+32.4%
GeneDx WGSUnited States$1.56B+16%+15%-14%54.2×n/an/a
Alvotech ALVOUnited States$1.62B+38%-14%12%22.6×n/an/a
Personalis PSNLUnited States$1.62B+88%+17%-157%n/an/an/a
ANI Pharmaceuticals ANIPUnited States$1.62B-13%+26%15%7.5×-7.6%+33.5%
Butterfly Network BFLYUnited States$1.63B+38%+39%-36%n/an/an/a
Nurix Therapeutics NRIXUnited States$1.54B-14%+739%41%n/an/an/a
Precigen PGENUnited States$1.53B0%+2,388%21%7.3×n/an/a
Kailera Therapeutics KLRAUnited States$1.53B-41%n/an/an/an/an/a
agilon health AGLUnited States$1.52B+12%+2%-2%34.1×n/an/a
Korsana Biosciences KRSAUnited States$1.52B+54%-64%-5,277%n/an/an/a
Braveheart Bio BRVEUnited States$1.67Bn/an/an/an/an/an/a
Inspire Medical Systems INSPUnited States$1.68B+32%0%2%41.3×28.7%+51.2%
Kestra Medical Technologies KMTSUnited States$1.69B+36%+61%-134%n/an/an/a
DENTSPLY SIRONA XRAYUnited States$1.69B-13%-1%5%6.8×11.2%+1.9%
Maze Therapeutics MAZEUnited States$1.71B+27%-100%-821%n/an/an/a
Astrana Health ASTHUnited States$1.47B-24%+35%3%17.6×7.4%+35.9%

BellRing Brands bonds and credit

BellRing Brands has 1 bond outstanding with $840M face value. The agencies rate it B+; its bonds trade like B. Weighted yield 8.30%, a spread of 367 bp over government bonds.

Every bond, yield and spread in the cockpit →

Questions

Which companies are BellRing Brands's closest peers?
The cockpit's peer set: Sonida Senior Living (SNDA), Vir Biotechnology (VIR), Enovis (ENOV), Sarepta Therapeutics (SRPT), GeneDx (WGS), Alvotech (ALVO), Personalis (PSNL), ANI Pharmaceuticals (ANIP).
Is BellRing Brands expensive compared with its peers?
On forward p/e it trades at 10.6× against a peer median of 17.6×, 5th cheapest of 10 in its peer set.
How has BellRing Brands stock performed?
Over six months to 18 Nov 2026 the shares returned +52.3% against +3.0% for the median peer; over one year -46.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.